4th Translational Genomics & Epigenomics Symposium
September 19 & 20, 2024
Guardant Health is committed to revolutionizing cancer care through cutting-edge genomic profiling and comprehensive liquid biopsy testing. Our extensive range of tests provide essential insights that support patients throughout their entire cancer journey:
Guardant Shield: Focuses on early cancer detection and screening to identify potential issues before symptoms arise.
Guardant Reveal: Monitors minimal residual disease (MRD) and assesses the risk of recurrence
Guardant 360: Expands treatment options with a broad panel of biomarkers, including all guideline-recommended markers for advanced solid tumors, and is supported by extensive commercial and Medicare coverage.
By leveraging cutting-edge diagnostic technologies, Guardant Health strives to deliver detailed genetic insights that facilitate personalized treatment strategies and ultimately enhance patient outcomes.
Our Mission:
Improve human health by unlocking the power of the genome
Who We Are:
We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health. Our products help pioneer advances in oncology, genetic and infectious diseases, reproductive health, and beyond. Our technology empowers continued innovation toward positive and impactful people- and planet-healing solutions.
Created by scientists for scientists, NEB prioritizes the advancement of science, stewardship of the environment, and giving back to the world around us in everything we do. Since our establishment in 1974, we have remained committed to developing high quality, innovative products that not only empower your research but also our own. Our profits have always funded an extensive research program, which we believe is critical for staying connected to our customers and helping to drive scientific breakthroughs. From our founding principles to our unique corporate culture, NEB’s philosophy can be distilled down to three core values: passion, humility and being genuine.
NEB offers the largest selection of recombinant and native enzymes for genomic research. While restriction enzymes remain part of our core product portfolio, our ever-expanding catalog also includes products related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, we are also focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development and nucleic acid vaccines.
Norgen Biotek is a fully-integrated Canadian biotechnology company established in 1998 and located in Thorold, Ontario. Founded by Dr. Yousef Haj-Ahmad, MSc, PhD, Norgen holds over thirty-five issued and pending patents and has developed a unique platform technology based on proprietary resin/matrix for the purification, concentration, and clean-up of biomolecules. Norgen Biotek is dedicated to pioneering innovative life-science research solutions that drive groundbreaking discoveries. The state-of-the-art 36,000 square foot facility has multiple ISO certifications and is designed to support a wide range of research and development endeavors.
Norgen’s mission is to deliver the highest quality products and services for sample collection, preservation, analyte extraction, pathogen detection, and NGS, ensuring clients can achieve their research goals efficiently and effectively. Specializing in RNA, DNA, exosomes, and protein extraction, Norgen focuses on challenging sample types like those with high impurities or ultra-low input. Their proprietary Silicon Carbide technology enables the high-quality extraction and clean-up of analytes for various research applications and diagnostics.
Norgen Biotek is committed to providing unparalleled quality and cost-effective solutions. Continuous improvement of business practices, manufacturing operations, and Quality Control (QC) procedures, adhering to industry standards, ensures that customer expectations are exceeded.
QIAGEN serves more than 500,000 customers globally, all seeking insights from DNA, RNA and proteins – the building blocks of life. Using any biological sample – be it blood, a throat swab or many other materials - we help our customers advance science and improve outcomes for people everywhere. Our products for molecular research and testing serve a wide range of applications from basic life sciences research to clinical healthcare. Together, we are making improvements in life possible.
Discover more at http://www.qiagen.com
Conquering today’s genetic challenges can help shape a better future for us all. By offering an extensive range and scope of pioneering Applied Biosystems solutions, Thermo Fisher Scientific helps bring tomorrow’s genetic revolution within reach. From foundational technologies such as qPCR, microarray, and CE to cutting-edge innovations such as digital PCR, we are your one-stop shop for your entire genetic analysis workflow, all manufactured under the highest quality standards and backed by unsurpassed global service and support.